TScan Therapeutics, Inc. (TCRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 132.77M | 152.41M | 188.16M | 221.13M | 254.84M | 292.72M | 274.08M | 299.53M | 164.72M | 194.24M | 217.57M | 242.22M |
| Cash & Short-Term Investments | 128.06M | 152.41M | 184.45M | 218.04M | 251.69M | 290.11M | 271.12M | 297.68M | 162.78M | 192.04M | 215.42M | 208.84M |
| Cash Only | 128.06M | 152.41M | 169.51M | 169.39M | 154.11M | 178.69M | 133.12M | 242.16M | 140.51M | 133.36M | 155.19M | 208.84M |
| Short-Term Investments | 0 | 0 | 14.95M | 48.65M | 97.58M | 111.42M | 138M | 55.52M | 22.27M | 58.69M | 60.23M | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.93M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | 922.89 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.71M | 0 | 3.71M | 3.08M | 3.15M | 2.61M | 2.96M | 1.85M | 0 | 2.19M | 2.14M | 1.45M |
| Total Non-Current Assets | 69.22M | 76.38M | 74.06M | 77.43M | 77.87M | 78.4M | 73.94M | 75.34M | 76.11M | 77.91M | 73.81M | 74.7M |
| Property, Plant & Equipment | 64.13M | 0 | 68.74M | 70.62M | 71.09M | 71.6M | 67.1M | 68.56M | 69.43M | 71.23M | 67.13M | 68.03M |
| Fixed Asset Turnover | 0.02x | - | 0.04x | 0.04x | 0.03x | 0.01x | 0.02x | 0.01x | 0.01x | 0.10x | 0.06x | 0.05x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 5.03M | 5.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.03M |
| Other Non-Current Assets | 5.1M | 71.35M | 288K | 6.81M | 6.79M | 6.8M | 6.84M | 6.78M | 6.68M | 6.68M | 6.68M | 1.65M |
| Total Assets | 201.99M | 228.79M | 262.23M | 298.56M | 332.71M | 371.12M | 348.03M | 374.87M | 240.83M | 272.15M | 291.38M | 316.92M |
| Asset Turnover | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.03x | 0.01x | 0.01x |
| Asset Growth % | -39.29% | -38.35% | -24.65% | -20.36% | 38.15% | 36.37% | 19.44% | 18.28% | 38.75% | 36.7% | 76.11% | 107.93% |
| Total Current Liabilities | 19.97M | 18.7M | 29.21M | 31.32M | 29.82M | 35.96M | 28.66M | 38.57M | 31.48M | 29.82M | 33.15M | 35.12M |
| Accounts Payable | 2.3M | 1.24M | 6.35M | 4.54M | 4.97M | 4.28M | 3.65M | 3.11M | 2.12M | 2.37M | 3.2M | 3.39M |
| Days Payables Outstanding | 230.13 | - | - | - | - | - | - | - | - | 200.17 | - | - |
| Short-Term Debt | 7.44M | 7.17M | 6.9M | 0 | 0 | 0 | 0 | 13.95M | 6.8M | 3.35M | 1.11M | 4.21M |
| Deferred Revenue (Current) | 1.64M | 0 | 5.19M | 7.7M | 10.27M | 11.7M | 9.93M | 10.7M | 0 | 10.14M | 15.21M | 19.21M |
| Other Current Liabilities | 8.59M | 10.29M | 5.01M | 3.85M | 2.22M | 6.92M | 5.05M | 3.67M | 10.69M | 5.9M | 4.43M | 5.08M |
| Current Ratio | 6.65x | 8.15x | 6.44x | 7.06x | 8.55x | 8.14x | 9.56x | 7.77x | 5.23x | 6.51x | 6.56x | 6.90x |
| Quick Ratio | 6.65x | 8.15x | 6.44x | 7.06x | 8.55x | 8.14x | 9.56x | 7.77x | 5.23x | 6.51x | 6.56x | 6.90x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 85.1M | 86.97M | 89M | 90.53M | 92.69M | 94.19M | 90.28M | 81.08M | 86.39M | 91.46M | 89.27M | 91.2M |
| Long-Term Debt | 52.45M | 32.53M | 32.41M | 32.3M | 32.18M | 32.07M | 30.65M | 20.11M | 23.45M | 26.7M | 28.84M | 29.72M |
| Capital Lease Obligations | 0 | 54.44M | 56.3M | 58.12M | 59.88M | 60.74M | 55.81M | 57.01M | 58.18M | 59.14M | 52.66M | 53.81M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 32.65M | 0 | 278K | 113K | 124K | 135K | 146K | 0 | 4.76M | 0 | 12K | 24K |
| Total Liabilities | 105.07M | 105.67M | 118.2M | 121.85M | 122.51M | 130.15M | 118.94M | 119.65M | 117.86M | 121.28M | 122.42M | 126.32M |
| Total Debt | 59.88M | 94.14M | 95.62M | 96.7M | 97.04M | 97.38M | 90.36M | 94.69M | 91.76M | 92.43M | 86.98M | 87.74M |
| Net Debt | -68.17M | -58.27M | -73.88M | -72.69M | -57.07M | -81.31M | -42.76M | -147.47M | -48.75M | -40.93M | -68.21M | -121.1M |
| Debt / Equity | 0.62x | 0.76x | 0.66x | 0.55x | 0.46x | 0.40x | 0.39x | 0.37x | 0.75x | 0.61x | 0.51x | 0.46x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -42.29x | -31.73x | -50.09x | -52.63x | -49.26x | -44.67x | -30.20x | -32.26x | -30.43x | -22.02x | -22.42x | -23.81x |
| Total Equity | 96.92M | 123.12M | 144.02M | 176.71M | 210.2M | 240.97M | 229.09M | 255.22M | 122.97M | 150.87M | 168.96M | 190.61M |
| Equity Growth % | -53.89% | -48.91% | -37.13% | -30.76% | 70.94% | 59.72% | 35.59% | 33.9% | 57.61% | 51.73% | 44.83% | 44.78% |
| Book Value per Share | 0.75 | 0.95 | 1.11 | 1.36 | 1.62 | 1.99 | 1.93 | 2.25 | 1.30 | 1.59 | 1.78 | 4.04 |
| Total Shareholders' Equity | 96.92M | 123.12M | 144.02M | 176.71M | 210.2M | 240.97M | 229.09M | 255.22M | 122.97M | 150.87M | 168.96M | 190.61M |
| Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K |
| Retained Earnings | -533.53M | -504.86M | -481.88M | -446.18M | -409.22M | -375.1M | -339.29M | -309.4M | -277.74M | -247.6M | -227.98M | -204.99M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 2K | -4K | -4K | 51K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |